Healthcare provider profile · identity verified

Ruben E. Alvarez, MD

Internal Medicine · LOS ANGELES, CA · NPI 1598832511

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	648	237
Amlodipine Besylate	Amlodipine Besylate	414	147
Lisinopril	Lisinopril	395	131
Metformin Hcl	Metformin Hcl	362	126
Rosuvastatin Calcium	Rosuvastatin Calcium	256	104
Hydrochlorothiazide	Hydrochlorothiazide	251	92
Losartan Potassium	Losartan Potassium	250	87
Levothyroxine Sodium	Levothyroxine Sodium	240	77
Glipizide	Glipizide	236	87
Alendronate Sodium	Alendronate Sodium	210	70
Atenolol	Atenolol	210	65
Simvastatin	Simvastatin	195	63
Omeprazole	Omeprazole	182	81
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	161	37
Albuterol Sulfate Hfa	Albuterol Sulfate	160	62
Triamcinolone Acetonide	Triamcinolone Acetonide	146	74
Pantoprazole Sodium	Pantoprazole Sodium	143	62
Metoprolol Tartrate	Metoprolol Tartrate	139	44
Trazodone Hcl	Trazodone Hcl	129	57
Tamsulosin Hcl	Tamsulosin Hcl	126	48
Terazosin Hcl	Terazosin Hcl	123	46
Gabapentin	Gabapentin	116	53
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	114	44
Furosemide	Furosemide	102	50
Meloxicam	Meloxicam	100	57
Jardiance	Empagliflozin	99	31
Famotidine	Famotidine	80	39
Humulin N	Insulin Nph Human Isophane	76	28
Alprazolam	Alprazolam	72	13
Metformin Hcl Er	Metformin Hcl	72	30
Lorazepam	Lorazepam	70	21
Finasteride	Finasteride	68	23
Ibuprofen	Ibuprofen	67	32
Potassium Chloride	Potassium Chloride	64	27
Acetaminophen-Codeine	Acetaminophen With Codeine	58	19
Buspirone Hcl	Buspirone Hcl	56	25
Pradaxa	Dabigatran Etexilate Mesylate	49	15
Valacyclovir	Valacyclovir Hcl	48	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	46	46
Allopurinol	Allopurinol	46	21
Hydralazine Hcl	Hydralazine Hcl	44	16
Clopidogrel	Clopidogrel Bisulfate	43	17
Clonazepam	Clonazepam	42	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	18
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	42	11
Prednisone	Prednisone	42	26
Cephalexin	Cephalexin	41	32
Fluticasone Propionate	Fluticasone Propionate	41	18
Tramadol Hcl	Tramadol Hcl	41	27
Zolpidem Tartrate	Zolpidem Tartrate	39	11
Verapamil Er	Verapamil Hcl	38	14
Mirtazapine	Mirtazapine	36	17
Naproxen	Naproxen	34	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	34	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	33	33
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	33	33
Lactulose	Lactulose	33	15
Pioglitazone Hcl	Pioglitazone Hcl	33	11
Humulin R	Insulin Regular, Human	32	12
Metronidazole	Metronidazole	32	16
Propranolol Hcl	Propranolol Hcl	32	suppressed
Spironolactone	Spironolactone	32	13
Colchicine	Colchicine	31	12
Bisoprolol Fumarate	Bisoprolol Fumarate	29	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	25
Hydrocortisone	Hydrocortisone	29	16
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	28	14
Carvedilol	Carvedilol	26	11
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Lovastatin	Lovastatin	25	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	24	suppressed
Benazepril Hcl	Benazepril Hcl	23	suppressed
Eliquis	Apixaban	23	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	23	suppressed
Azithromycin	Azithromycin	22	18
Alvesco	Ciclesonide	21	11
Lidocaine	Lidocaine	21	suppressed
Nitroglycerin	Nitroglycerin	21	suppressed
Testosterone	Testosterone	21	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	13
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Amoxicillin	Amoxicillin	19	16
Donepezil Hcl	Donepezil Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Acyclovir	Acyclovir	18	13
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Ciclopirox	Ciclopirox	17	suppressed
Glipizide-Metformin	Glipizide/Metformin Hcl	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Sertraline Hcl	Sertraline Hcl	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Brilinta	Ticagrelor	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Ozempic	Semaglutide	11	suppressed
Proctozone-Hc	Hydrocortisone	11	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error